Localization and Identification of Granzymes A and B-expressing Cells in Normal Human Lymphoid Tissue and Peripheral Blood

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1995 Apr 1

PMID 7697916

Citations 15

Authors

J A Kummer

A M Kamp

T M Tadema

W Vos

C J Meijer

C E Hack

Affiliations

Soon will be listed here.

Abstract

Cytoplasmic granules from activated natural killer (NK) and cytotoxic T lymphocytes (CTL) contain a pore-forming protein, perforin, and several homologous serine proteinases called granzymes. Expression of these proteins correlates with the cytolytic potential of cytotoxic lymphocytes. Using a panel of MoAbs specific for human granzyme A and B, respectively, expression of these proteinases in non-pathological lymphoid tissue and peripheral blood lymphocyte (PBL) subpopulations was investigated. Using immunohistochemistry and double stainings, the phenotype of granzyme-expressing cells in lymphoid tissue was investigated. Granzyme-positive cells were detected in all lymphoid tissues tested. No large differences in the number and distribution between granzyme A- and granzyme B-positive cells were observed. The highest number of positive cells was located in the red pulp of the spleen. Significant numbers were detected in tonsil, lymph nodes, liver and thymus. Low numbers were present in the lamina propria of non-inflamed stomach, small intestine and colon. Phenotypic analysis and cell sorting showed that most of the granzyme-positive cells in lymphoid tissue and PBL consisted of CD3-CD16+CD56+ lymphocytes. Hardly any granzyme-positive CD3+CD8+ CTL were present in peripheral blood. The synthesis of granzyme A as well as B by both CD3+CD16+CD56+ and CD3+CD8+ cells in peripheral blood was increased upon IL-2 stimulation. These results indicate that in normal lymphoid tissue the predominant cytolytic cell population is formed by the NK cells, and activated CTL are rare.

Citing Articles

Integrative histopathological and immunophenotypical characterisation of the inflammatory microenvironment in spitzoid melanocytic neoplasms.

Hillen L, Vandyck H, Leunissen D, de Greef B, Bosisio F, Zur Hausen A Histopathology. 2020; 78(4):607-626.

PMID: 32970867 PMC: 7894529. DOI: 10.1111/his.14259.

HLA-G dimer targets Granzyme B pathway to prolong human renal allograft survival.

Ajith A, Portik-Dobos V, Nguyen-Lefebvre A, Callaway C, Horuzsko D, Kapoor R FASEB J. 2019; 33(4):5220-5236.

PMID: 30620626 PMC: 6436663. DOI: 10.1096/fj.201802017R.

Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.

van Kempen P, Noorlag R, Swartz J, Bovenschen N, Braunius W, Vermeulen J Cancer Immunol Immunother. 2016; 65(5):575-85.

PMID: 26993499 PMC: 4840222. DOI: 10.1007/s00262-016-1819-4.

Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors.

Vermeulen J, Van Hecke W, Spliet W, Villacorta Hidalgo J, Fisch P, Broekhuizen R PLoS One. 2016; 11(3):e0151465.

PMID: 26963506 PMC: 4786147. DOI: 10.1371/journal.pone.0151465.

Tumor-infiltration of T-lymphocytes is inversely correlated with clinicopathologic factors in endometrial adenocarcinoma.

Jung I, Kim S, Suh D, Kim K, Lee C, Yoon M Obstet Gynecol Sci. 2014; 57(4):266-73.

PMID: 25105099 PMC: 4124087. DOI: 10.5468/ogs.2014.57.4.266.

References

Vroom T, Scholte G, Ossendorp F, Borst J . Tissue distribution of human gamma delta T cells: no evidence for general epithelial tropism. J Clin Pathol. 1991; 44(12):1012-7. PMC: 494970. DOI: 10.1136/jcp.44.12.1012. View

Griffiths G, Mueller C . Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. Immunol Today. 1991; 12(11):415-9. DOI: 10.1016/0167-5699(91)90145-J. View

Young L, Joag S, Lin P, Luo S, Zheng L, Liu C . Expression of cytolytic mediators by synovial fluid lymphocytes in rheumatoid arthritis. Am J Pathol. 1992; 140(5):1261-8. PMC: 1886510. View

Lu P, Garcia-Sanz J, Lichtenheld M, Podack E . Perforin expression in human peripheral blood mononuclear cells. Definition of an IL-2-independent pathway of perforin induction in CD8+ T cells. J Immunol. 1992; 148(11):3354-60. View

Shiver J, Su L, Henkart P . Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell. 1992; 71(2):315-22. DOI: 10.1016/0092-8674(92)90359-k. View

Vanguri P, Lee E, Henkart P, Shin M . Hydrolysis of myelin basic protein in myelin membranes by granzymes of large granular lymphocytes. J Immunol. 1993; 150(6):2431-9. View

Kummer J, Kamp A, van Katwijk M, Brakenhoff J, Radosevic K, van Leeuwen A . Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteins. J Immunol Methods. 1993; 163(1):77-83. DOI: 10.1016/0022-1759(93)90241-x. View

Salcedo T, Azzoni L, Wolf S, Perussia B . Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol. 1993; 151(5):2511-20. View

Doherty P . Cell-mediated cytotoxicity. Cell. 1993; 75(4):607-12. DOI: 10.1016/0092-8674(93)90480-e. View

10.

Froelich C, Zhang X, Turbov J, Hudig D, Winkler U, Hanna W . Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes. J Immunol. 1993; 151(12):7161-71. View

11.

Heusel J, Wesselschmidt R, Shresta S, Russell J, Ley T . Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell. 1994; 76(6):977-87. DOI: 10.1016/0092-8674(94)90376-x. View

12.

de Bruin P, Kummer J, van der Valk P, van Heerde P, Kluin P, Willemze R . Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization. Blood. 1994; 84(11):3785-91. View

13.

Hudig D, Haverty T, Fulcher C, Redelman D, Mendelsohn J . Inhibition of human natural cytotoxicity by macromolecular antiproteases. J Immunol. 1981; 126(4):1569-74. View

14.

Perussia B, STARR S, Abraham S, Fanning V, Trinchieri G . Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J Immunol. 1983; 130(5):2133-41. View

15.

Macdermott R, Schmidt R, Caulfield J, Hein A, Bartley G, Ritz J . Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis. J Exp Med. 1985; 162(6):1771-87. PMC: 2187999. DOI: 10.1084/jem.162.6.1771. View

16.

Rolstad B, Herberman R, Reynolds C . Natural killer cell activity in the rat. V. The circulation patterns and tissue localization of peripheral blood large granular lymphocytes (LGL). J Immunol. 1986; 136(8):2800-8. View

17.

Gershenfeld H, Weissman I . Cloning of a cDNA for a T cell-specific serine protease from a cytotoxic T lymphocyte. Science. 1986; 232(4752):854-8. DOI: 10.1126/science.2422755. View

18.

Lanier L, Le A, Civin C, Loken M, Phillips J . The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986; 136(12):4480-6. View

19.

Simon M, Simon H, Fruth U, Epplen J, Muller-Hermelink H, Kramer M . Cloned cytolytic T-effector cells and their malignant variants produce an extracellular matrix degrading trypsin-like serine proteinase. Immunology. 1987; 60(2):219-30. PMC: 1453214. View

20.

Schmid J, Weissmann C . Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen-stimulated human leukocytes. J Immunol. 1987; 139(1):250-6. View